Circulating levels of insulin-like growth factor I, its binding proteins -1, -2, -3, C-peptide and risk of postmenopausal breast cancer

International Journal of Cancer

Volumn 106, Issue 1, 2003, Pages 90-95

  Keinan Boker, Lital ^a   Bueno De Mesquita, H Bas ^b   Kaaks, Rudolf ^c   Van Gils, Carla H ^a   Van Noord, Paul A H ^a   Rinaldi, Sabina ^c   Riboli, Elio ^c   Seidell, Jaap C ^b,d   Grobbee, Diederick E ^a   Peeters, Petra H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Breast cancer; C peptide; IGF binding proteins (IGFBP) 1, 2, 3; Insulin like growth factor I (IGF I); Postmenopausal; Prospective

Indexed keywords

C PEPTIDE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE; AGED; ARTICLE; BLOOD DONOR; BODY MASS; BREAST CANCER; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; DELIVERY; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; NETHERLANDS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

AGED; APOPTOSIS; BREAST NEOPLASMS; C-PEPTIDE; COHORT STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS;

EID: 0037869234     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11193     Document Type: Article

References (49)

1. Le Roith D. Insulin-like growth factors. N Engl J Med 1997;336:633-40.
2. Krywicki RF, Yee D. The insulin-like growth factor family of ligands, receptors and binding proteins. Breast Cancer Res Treat 1992:22:7-19.
3. De Leon DD, Bakker B, Wilson DM, Lamson G, Rosenfeld RG. Insulin-like growth factor binding proteins in human breast cancer cells: relationship to hIGFBP-2 and hlGFBP-3. J Clin Endocrinol Metab 1990;71:530-2.
4. Baker J, Liu J-P, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73-82.
5. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effect of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrinol Rev 2000;21:215-44.
6. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000;36:1224-8.
7. Smith GD, Gunnell D, Holly J. Cancer and insulin-like growth factor I. Br Med J 2000;321:847-8.
8. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-6.
9. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev 1995;16:3-34.
10. Werner H, Le Roith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996;68:183-223.
11. Kleinberg DL. Role of IGF-I in normal mammary development. Breast Cancer Res Treat 1998;47:201-8.
12. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A. Plasma insulin-like growth factor-I (IGF-I) concentrations in human breast cancer. Eur J Cancer 1993; 29A:492-7.
13. Pollak MN. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast. Cancer Res Treat 1998;47: 209-17.
14. Cullen KJ, Allison A, Martire I, Ellis M, Singer C. Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast. Cancer Res Treat 1992;22:21-9.
15. De Leon DD Wilson, DM, Powers M, Rosenfeld RG. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors 1992;6: 327-36.
16. Peyrat JP, Bonneterre J. Type 1 IGF receptor in human breast diseases. Breast. Cancer Res Treat 1992;22:59-67.
17. Brünner, N, Moser, C, Clarke, R, Cullen, K. IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence. Breast Cancer Res Treat 1992;22:39-45.
18. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 1986;46:4613-9.
19. Figueroa JA, Yee D. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res Treat 1992;22: 81-90.
20. Gill ZP, Perks CM, Newcomb PV, Holly JM. Insulin-like growth factor-binding protein 3 (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF dependent manner. J Biol Chem 21997;72:25602-7.
21. Karas M, Danilenko M, Fishman D, Le Roith D, Levy J, Sharon Y. Membrane-associated insulin-like growth factor binding protein-3 inhibits insulin-like growth factor-I induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells. J Biol Chem 1997;272:16514-20.
22. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2000;92:191-17.
23. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-6.
24. Lacey JV Jr, Hsing AW, Fillmore C-M, Hoffman S, Helzsouer K, Comstock GW. Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study. Cancer Epidemiol Biomark Prev 2001;10:1101-2.
25. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB. Serum levels of insulin-like growth factor (IGF-I), IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 2000;85:4258-65
26. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-1606.
27. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomark Prev 2000;9:345-9.
28. Palmqvist R, Hallmans G, Rinakdi S, Biessy C, Stenling R, Riboli E, Kaaks R. Plasma insulin-like growth factor I, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in Northern Sweden. Gut 2002;50:642-6.
29. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-bonding protein-3. J. Natl Cancer Inst 1999;91:620-5.
30. Probst-Hensch NM, Yuan JM, Stanczyk FZ, Gao YT, Ross RK, Yu MC. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001;85:1695-9.
31. Lukanova A, Toniolo P, Akhmedkhanov A, Biessy C, Naley NJ, Shore RE, Riboli E, Rinaldi S, Kaaks R. A prospective study of insulin-like growth factor-I, IGF-binding protiens-1, -2 and -3 and lung cancer risk in women. Int J Cancer 2001;92:888-92.
32. London SJ, Yuan JM, Travlos GS, Gao YT, Wilson RE, Ross RK, Yu MC. Insulin-like growth factor I, IGF-binding protein 3 and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst 2002;94:749-54.
33. Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-carotene and retinol efficacy trial cohort. Cancer Epidemiol Biomarkers Prev 2002;11:1413-8.
34. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud D, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
35. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrér JMG, Koenig KL, Lukanova A, Shore RE, Zeleniuch-Jacquotte A. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-32.
36. Kaaks R, Lundin E, Manjer J, Rinaldi S, Biessy C, Söderberg S, Lenner P, Janzon L, Riboli E, Berglund G, Hallmans G. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden. Cancer Caus Control 2002;13:307-16.
37. Keinan Boker L, van Noord PAH, van der Schouw YT Koot, VCM, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PHM. Prospect-EPIC Utrecht: Study design and characteristics of the cohort population. Eur J Epidemiol 2001;17:1047-53.
38. Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, Oberman-de Boer GL, Kromhout D. Cardiovascular disease risk factors in The Netherlands. Neth J Cardiol 1993;6:205-10.
39. SPSS Inc. Statistical Package version 9.0. Chicago. 1998.
40. Egret for windows. Cytel statistical software corporation, Cambridge MA, USA.
41. Smith JC, Lewis S, Holbrook J, Seidell K, Rose, A. Effect of heparine and citrate on measured concentrations of various analytes in plasma. Clin Chem 31987;3:814-6.
42. Groschl M, Wanger R, Dorr HG, Blum W, Rascher W, Dotsch J. Variability of leptin values measured from different sample matrices. Horm Res 2000;54:26-31.
43. Yang G, Lu G, Jin F, Dai Q, Best R, Shu X-O, Chen J-R, Pan X-Y, Shrubsole M, Zheng W. population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:1207-11.
44. Bruning PF, van Doom J, Bonfrér JMG, van Noord PAH, Korse CM, Linders TC, Hart AAM. Insulin-like growth factor binding protein-3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 1995;62:266-70.
45. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PL. Insulin and related factors in premenopausal breast cancer risk. Breast. Cancer Res Treat 1998;47:111-20.
46. Sachdev D, Yee D. The IGF system and breast cancer. Endocrin Related Cancer 2001;8:197-209.
47. Kaaks R, Lukanova A. Nutrition, hormones and breast cancer: is insulin the missing link? Cancer Caus Control 1996;7:569-71.
48. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor I. Proc Nutr Soc 2001;60:91-106.
49. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone induced IGF-I messenger ribonucleic acid. Endocrinology 1995;36:1296-302.